An Exploratory Correlative Study of Biomarkers in Patients With Metastatic Renal Cell Carcinoma Who Have Progressed After Sunitinib Therapy [SUBSTUDY OF 700021566]

Trial Profile

An Exploratory Correlative Study of Biomarkers in Patients With Metastatic Renal Cell Carcinoma Who Have Progressed After Sunitinib Therapy [SUBSTUDY OF 700021566]

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 16 Nov 2010

At a glance

  • Drugs Temsirolimus (Primary) ; Sorafenib
  • Indications Renal cancer
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 16 Nov 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top